Live webinar
Rights Issue Offer
Rua Bioscience is announcing a Rights Offer to existing shareholders
Sales, Capital Raise and Meetings
Rua Rau Hiwa is sourced under New Zealand's unique regulatory framework, which permits the inclusion of legacy genetics in the medicinal cannabis sector, Rau Hiwa T23 pays homage to the safekeepers of distinctive cannabis genetics in our community and Aotearoa, New Zealand.
Rua Bioscience releases Annual Report (FY24)
Rua releases Full Year Results (FY24)
Legacy cannabis genetics in Australia
Products, Patients and Podcast
Our latest update on Rua Bioscience
Market Insights and Update
Market Insights and Update slides from Rua Bioscience.
Nimbus Health Agreement Extended
Rua Bioscience extends its sales and distribution agreement with Nimbus Health of Germany
Expansion of Compassionate Access Programme
The Compassionate Access Programme has expaned to 37 patients per month thanks to the generosity of others.
Australian expansion
Rua Bioscience expands its product range in Australia.
Rua Bioscience partners with Cannprisma for trials in Portugal
Psilocybin mushroom programme
Rua Bioscience Impact Programme gains further support from Trust Tairawhiti
Rua Releases Half Year Results (HY24)
Expanding reach to Canada
2023 at a glance
Rua Bioscience Celebrates 2023 Scholars Driving Positive Change in Te Tairawhiti
Rua Bioscience Celebrates 2023 Scholars Driving Positive Change in Te Tairāwhiti
Changes to Supply Agreement with Cann Group
Market Update - Global Market Expansion with Unique New Zealand Genetics
Global Market Expansion with Unique New Zealand Genetics